NurExone Biologic Inc. (TSXV:NRX)
0.6800
-0.0100 (-1.45%)
At close: Dec 19, 2025
-8.11% (1Y)
| Market Cap | 61.66M |
| Revenue (ttm) | n/a |
| Net Income (ttm) | -9.10M |
| Shares Out | 90.68M |
| EPS (ttm) | -0.12 |
| PE Ratio | n/a |
| Forward PE | n/a |
| Dividend | n/a |
| Ex-Dividend Date | n/a |
| Volume | 2,500 |
| Average Volume | 26,049 |
| Open | 0.6800 |
| Previous Close | 0.6900 |
| Day's Range | 0.6800 - 0.6800 |
| 52-Week Range | 0.5400 - 1.1400 |
| Beta | 0.22 |
| RSI | 44.21 |
| Earnings Date | Nov 28, 2025 |